Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia
NCT ID: NCT05915663
Last Updated: 2024-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
2400 participants
INTERVENTIONAL
2024-10-01
2027-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital.
Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route.
Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Three Methods for NG Tube Placement
NCT03699306
Venous Site for Central Catheterization
NCT01479153
Comparison of Different Methods of Nasogastric Tube Insertion in Anesthetized and Intubated Patients
NCT02557204
End-Tidal CO2 (etCO2) and pH in the Correct Naso-gastric Tube Placement
NCT03934515
Verification of Correct Positioning of a Gastric Tube by Ultrasonography
NCT02866123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nasogastric
nasogastric tube in period 1 and orogastric tube in period 2
nasogastric tube and orogastric tube
nasogastric tube in period 1 and orogastric tube in period 2
Orogastric
orogastric tube in period 1 and nasogastric tube in period 2
orogastric tube and nasogastric tube
orogastric tube in period 1 and nasogastric tube in period 2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nasogastric tube and orogastric tube
nasogastric tube in period 1 and orogastric tube in period 2
orogastric tube and nasogastric tube
orogastric tube in period 1 and nasogastric tube in period 2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult
* Requiring a gastric tube
* With an expected duration of mechanical ventilation of more than 48 hours
* Affiliated to social security
* Patient or relative consent or, failing that, emergency inclusion of the patient
Exclusion Criteria
* Patients under legal protection: curatorship and guardianship
* Contraindication to placing a gastric tube through the nose or mouth
* Patients who already have a gastric tube when they enter the service
* Patient intubated for more than 24 hours
* Patient intubated via the nasotracheal route
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier le Mans
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Du Mans
Le Mans, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Saletes J, Guitton C, Valleroy J, Guillarme S, Haubertin C, Paris G, Muller L, Rousseau C, Gamon P, L'Hotellier S, Forel JM, Roussel C, Garin A, Morand C, Maury E, Mangeard N, Menard L, Arnaud PY, Lejeune A, Rouanet E, Callahan JC. Effect of nasogastric versus orogastric tube placement on ventilator-associated pneumonia incidence in critically ill patients: a study protocol for a cluster randomised crossover trial in 16 intensive care units in France (SONG trial). BMJ Open. 2025 Sep 8;15(9):e099840. doi: 10.1136/bmjopen-2025-099840.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHM-2022/S03/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.